HealthDay News — Stimulus control therapy and sleep restriction therapy are viable single-component treatments for chronic insomnia, according to a study published in the June issue of Worldviews on Evidence-Based Nursing.

Souraya Sidani, Ph.D., from the Daphne Cockwell School of Nursing at Ryerson University in Toronto, and colleagues compared the effect of three single-component therapies (sleep education and hygiene, stimulus control therapy, or sleep restriction therapy) and one multiple-component therapy on short-term sleep outcomes among 517 persons with chronic insomnia.

Related Articles

The researchers found that sleep education and hygiene was least effective, while stimulus control therapy, sleep restriction therapy, and multiple-component therapy were moderately effective. For perceived insomnia severity and some sleep parameters, stimulus control therapy and sleep restriction therapy demonstrated slightly higher remission rates than multiple-component therapy.

“Single-component insomnia treatment may be more convenient to implement in the primary care setting due to the reduced number of treatment recommendations compared to multiple-component therapy,” the authors write.

Abstract/Full Text (subscription or payment may be required)